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a b s t r a c t
Objective: To compare the efficacy of a new dentifrice containing 1.5% arginine and
1450 ppm fluoride to a positive control dentifrice containing 1450 ppm fluoride alone in
arresting and reversing primary root caries lesions in adults.
Study design: A total of 3779 subjects from Piracicaba, Sa¨o Paulo, Brazil were screened; 284
had at least one leathery primary root caries lesion and were eligible for the study. The new
dentifrice contained 1.5% arginine, an insoluble calcium compound, and 1450 ppm fluoride,
as sodium monofluorophosphate; the matched positive control dentifrice contained
1450 ppm fluoride. One lesion for each subject was selected for inclusion in the study
and was examined at baseline, 3 and 6 months.
Results: A total of 253 subjects completed the study with 129 of 144 subjects included in the
final statistical analysis for the test dentifrice and 124 of 140 for the positive control. The
mean age of subjects was 45.7 (9.19) years and 56.5% were female. After 6 months product
use, 70.5% of root caries lesions improved for subjects using the arginine-containing
dentifrice compared to 58.1% for subjects using the positive control. The difference in
the number of root caries lesions becoming hard in the two groups was statistically
significant ( p = 0.038).
Conclusion: A new dentifrice containing 1.5% arginine, an insoluble calcium compound, and
1450 ppm fluoride, as sodium monofluorophosphate, provided statistically significantly
superior efficacy in arresting and reversing active root caries lesions in adults compared
to a matched positive control dentifrice containing fluoride alone.
# 2013 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Despite the highly successful introduction of fluoride, dental
caries remains a prevalent oral disease, and cavities remain a* Corresponding author. Tel.: +44 161 232 4705; fax: +44 161 232 4700.
E-mail address: roger.p.ellwood@manchester.ac.uk (R.P. Ellwood).
0300-5712 # 2013 Elsevier Ltd.
doi:10.1016/j.jdent.2010.04.006
Open access under CC BY-NC-ND license.
 global public health problem. Historically, epidemiology
research has emphasized dental caries in young people.
Nonetheless, research shows that dental caries is important
throughout life because caries prevalence and severity
increases with age as secondary, or recurrent, caries begins
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have reported an increase in the prevalence of root caries as a
result of older adults retaining a higher number of teeth in
their oral cavity. The possibility that exposed root surfaces are
present in older adults increases the risk of caries develop-
ment and progression.2–5
There is undisputed evidence that fluoride has a beneficial
effect on de- and re-mineralization of both enamel and root
dentin.6–9 For this reason, brushing with fluoride toothpaste
remainsas thefirst lineofdefenseagainst rootcaries,helping to
remove plaque and acting as a fluoride delivery vehicle. In fact,
it isoneof the few interventions indentistrywhichhassurvived
the detailed scrutiny of the systematic review process.10
The extensive use of fluoridated dentifrice has led to a
decrease in dental caries prevalence worldwide, including
rapidly developing countries, such as Brazil.11 Despite the
evidence thatfluoridateddentifricehas playeda significant role
incontrollingcariesdevelopment, it cannotcompletelyprevent
dental caries – a disease continuum that progresses through a
series of stages from the formation of a reversible early de-
mineralized lesion to a cavity that can no longer be reversed.1
One reason why fluoride cannot completely prevent the caries
process is that dental caries is a complex, multi-factorial
process; it involves residual dental plaque biofilm, a susceptible
tooth surface, and sugar, and it occurs at the interface where
bacterial metabolism of these dietary sugars produces acids.
Fluoride is effective in preventing cavities because it targets the
tooth surface where it reverses and repairs early caries lesions
by driving calciumand phosphate back into the de-mineralized
hydroxyapatite. It also strengthens the hydroxyapatite by
integrating into the tooth structure as fluorapatite. In addition,
fluoride is effective inpreventing cavitiesbecause it reduces the
critical pH below which calcium and phosphate ions are lost
from the tooth surface, thereby reducing de-mineralization.1
However, fluoride does not target the root cause–dental plaque.
Therefore, there is good reason tobelieve thatnew technologies
should be investigated that have the potential to complement
and enhance the effects of fluoride by specifically targeting
dental plaque to reduce its pathogenicity. This could, at least in
principle,beaccomplishedbyreducingthenumbersofbacterial
species within the plaque biofilm that are associated with
caries, such as the mutans streptococci, or by modulating
biofilm metabolism to reduce the production and effects of
bacterial acid.1
Among the new technologies recently identified for their
potential oral health benefits is a novel combination of
arginine and an insoluble calcium compound. Arginine is a
semi-essential amino acid found in many foods, including
milk and its byproducts, meat, poultry, seafood, cereals and
nuts, which is considered safe for use in toothpaste. The
insoluble calciummay be in the form of calcium carbonate or
dicalcium phosphate dihydrate. By utilising the arginine
deiminase pathway in non-pathogenic, arginolytic organisms,
such as S. sanguis, arginine is metabolized to ammonia which,
in turn, can neutralize plaque acids and stabilize the residual
plaque biofilm on susceptible tooth surfaces.12,13 In so doing,
arginine can help prevent shifts in biofilm flora to acid-
producing bacteria, such as S. mutans, and maintain a
‘‘healthy’’ plaque after sugar challenge. Further, the insoluble
calcium compound can act a reservoir of free calcium ions toaugment the re-mineralization process helping to arrest and
reverse early caries lesions to prevent cavities.1
In a 2-year caries clinical trial, a fluoride-free calcium-based
toothpastecontainingargininebicarbonatewasevaluatedasan
alternative to regular fluoride toothpaste. The results of the
study show that the fluoride-free arginine/bicarbonate tooth-
paste reduced the formation of cavities as effectively as
1100 ppmfluoride toothpaste,demonstratingthat theapproach
is valid andapplicable to toothpaste.14 Basedupon the scientific
literature, this new arginine-containing toothpaste is particu-
larly noteworthy, as it is the first fluoride-free toothpaste to
demonstrate comparable clinical efficacy in preventing cavities
to the efficacy of 1100 ppm sodium fluoride toothpaste.1
Based upon the mechanism of action of arginine, which is
complementary to the well-known mechanism of action of
fluoride, arginine has the potential to significantly enhance the
caries preventive benefits of traditional fluoride dentifrices. For
this reason, anext generationdentifrice technology basedupon
1.5% arginine and 1450 ppmfluoride, asmonofluorophosphate,
in a calcium base has been developed and clinically validated.
Specifically, three coronal caries studies, using quantitative
light-induced fluorescence (QLF) to measure changes in early
caries lesions in children, have each shown that a new
dentifrice containing 1.5% arginine and 1450 ppm fluoride in
a calcium base is significantly more effective in arresting and
reversing coronal caries lesions than a dentifrice containing
1450 ppmfluoridealone.Twoadditionalstudieshavemeasured
changes in root caries lesions in adults, and each has shown
that the new dentifrice containing 1.5% arginine and 1450 ppm
fluoride in a calcium base is significantly more effective in
arresting and reversing root caries lesions than a dentifrice
containing 1450 ppm fluoride alone. Furthermore, it has been
proven to more effectively prevent the progression of caries to
cavitation thandentifricewithfluoride alone.ThisSpecial Issue
of Journal of Dentistry reports two of the coronal and one of the
root caries clinical studies.15–17 A Special Issue of Journal of
Clinical Dentistry reports the additional coronal and root caries
studies,18,19 together with a series of in situ and in vivo
mechanism of action studies which demonstrate that this
new technology works by targeting dental plaque to modulate
bacterial metabolism enhancing the production of ammonia
which, in turn, helps neutralize bacterial acids to reduce
fluctuations in plaque pH, thereby, reducing de-mineralization
and enhancing re-mineralization of early caries lesions.20,21
The aim of this study was to test the hypothesis that the
new dentifrice containing 1.5% arginine, an insoluble calcium
compound, and 1450 ppm fluoride as sodiummonofluoropho-
sphate (MFP) ismore effective than amatched, positive control
dentifrice containing 1450 ppm fluoride alone in hardening
primary root caries lesions in adults.2. Materials and methods
This 6-month randomized controlled clinical study was
conducted in groups of adults residing in Piracicaba, Sao Paulo,
Brazil. The drinking water at the study site contains approxi-
mately 0.7 ppm fluoride. Approval to conduct the study was
givenbytheResearchEthicsCommitteeof thePiracicabaDental
School, Sa¨o Paulo, Brazil.
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Fig. 1 – Disposition of subjects.
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subjects had to be at least 30 years of age, have at least eight
natural uncrowned teeth and at least one leathery root caries
lesion. Subjects were excluded if they had advanced peri-
odontal disease, had participated in another dental study
during the previous 3 months, had a history of allergy to oral
care or personal care consumer products or their ingredients,
or were pregnant or nursing. A total of 3779 subjects were
screened and of these 284 were found to meet the eligibility
criteria, entered into the study and allocated to one of the two
study products (Fig. 1).
Participants were allocated to one of two groups using a
sequence of codes randomly generated by the study adminis-
trator. The two groups comprised a positive control group
using a matched product containing 1450 ppm fluoride, as
sodiummonofluorophosphate (MFP), in a calcium base and an
experimental group using the test product containing 1.5%
arginine, and insoluble calcium compound, and 1450 ppm
fluoride, asMFP. Because the twoproducts contained the same
abrasive system, the relative dentin abrasion (RDA) values
were very similar, and both were much lower than the
maximum permitted RDA for daily use toothpastes. Within
the randomization, product allocationwas stratified according
age (two levels; 30–50 and 51–69) and number of lesions
present (two levels; 4 and 5 or more).
Participants were instructed to brush at least twice daily
with their assigned dentifrice and a Colgate plus Sensitive,
compact head, soft toothbrush (Colgate-Palmolive, New
York, NY) for 1 min. Prior to and during the course of the
study, a dental professional provided participants with
instruction in proper oral hygiene to ensure that the
toothpaste was being used as recommended. Two tubes of
dentifrice and a toothbrush were supplied to each subject at6-week intervals. The tubes were individually labelled for
each study participant and supplied in plain white contain-
ers to conceal the identity of the product. Only one type of
toothpaste was assigned per family and additional tubes of
toothpaste were available upon participant’s request. A
compliance check occurred in conjunction with the 6-week
deliveries of toothpaste. To help ensure that products were
being used by the study participants, at both the 3- and 6-
month examinations, empty and partially used tubes were
returned to the study site before additional toothpaste was
supplied.
One leathery lesion for each subject was selected for
inclusion in the study and examined at baseline, 3 and 6
months. When possible, lesions were chosen with clearly
demarcated borders on the buccal surfaces of teeth. In cases
where multiple suitable lesions were available, the most
anterior lesion was selected.3. Examination methods
Examinations were performed at baseline and after 3 and 6
months of product use by a single examiner. The clinical
assessment commenced with an examination of the soft and
hard tissues of the mouth. The methods described by Baysan
et al. were used to perform a detailed assessment of the
selected root caries lesion.22
3.1. Dental plaque
The amount of plaque overlying each lesion was measured
using the Plaque Index of Silness and Loe and scored as
follows23:
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1 = a thin filmof plaque adhering to the gingivalmargin and
adjacent area of the tooth. The plaque may be seen in situ
only after using the probe on the tooth surface.
2 = Moderate accumulation of soft deposits within the
gingival pocket or on the tooth and gingival margin which
can be seen with the naked eye.
3 = Abundance of soft matter within the gingival pocket
and/or on the tooth and gingival margin.
Dental plaque scores were recorded at the baseline
examination to ensure that the groupswere similar at baseline
with respect to this variable.
3.2. Lesion height, width and distance from the gingival
margin
The maximum height and width of the lesions was
measured to the nearest 0.5 mm using standard periodontal
probe with 1 mm markings (PCPUNC15, Hu Friedy, US). The
product of these two values was calculated and used to
estimate the ‘‘area’’ of the lesion which was used in
statistical analysis. The distance from the gingival margin
to the gingival border of the lesion was also measured to the
nearest 0.5 mm.
3.3. Hardness
The hardness of each lesion was defined as follows: a
soft lesion is one which permitted a sharp probe (No. 5
Sharp Explorer) to penetrate the lesion with ease, and there
was no resistance to its withdrawal; a leathery lesion
permitted a sharp probe to penetrate the surface, but there
was some resistance to its withdrawal; a hard lesion is
comparable in hardness to the surrounding sound root
dentine.Table 2 – Cross-tabulation of baseline hardness with the 3- and
withdrawn due to the tooth being filled or extracted for the tw
Group Baseline 3 months
Leathery Soft Leathery Ha
1.5% Arginine/1450 MFP n 129 0 89 39
% 100 0 69.0 30
1450 MFP n 124 1 71 50
% 100 0.8 57.3 40
3 months; 1.5% Arginine/1450 ppm F 39/129 (30.2%) became hard compa
1450 ppm F 91/129 (70.5%) became hard compared to 1450 ppm F 72/124
Table 1 – Baseline mean plaque score, distance of lesion from t
lesions for the two study groups (mean (SD)).
1.5% Arginine/1450 MFP
N = 129
Lesion plaque score 1.56 (1.01)
Distance from Gingival margin 0.52 (0.82)
Lesion area 4.11 (4.05)
Number of lesions 3.35 (3.29)3.4. Statistical analysis
The number of lesions becoming hard was compared for the
two study groups using a Chi2 test at the 3- and 6-month
examinations. The number of lesions becoming hard at the 6-
month examination was the primary outcome for the study.
Further analysis using a logistic regression model was used to
control for potential baseline imbalance of lesion character-
istics. The level of statistical significance was set at p < 0.05.4. Results
A total of 129 of 144 subjectswere included in thefinal statistical
analysis for theexperimentalgroupand124of140 inthepositive
control group. Reasons for loss from the study are tabulated in
Fig. 1. The mean age of subjects included in the final statistical
analysis was 45.7 (9.19) years and 56.5% were female.
4.1. Baseline balance
The baseline characteristics of plaque, lesion area, distance of
the lesion from the gingival margin and number of lesions per
subjects are shown in Table 1. It can be seen that there was
some evidence of baseline imbalance with lesions tending to
be larger in area (p = 0.022) in the arginine-containing
dentifrice group than in the positive control group. The results
of the logistic regression analysis, show in Table 3, indicate
that these differences would increase the probability that a
lesion would not become hard for the arginine-containing
dentifrice group compared to the positive control.
4.2. Lesion hardness
Lesion hardness scores are shown in Table 2. At the baseline
examination, in accordance with the inclusion criteria, all6-month scores for subjects completing the study or being
o study groups.
6 months
rd Filled Soft Leathery Hard Filled Extracted
1 0 34 91 3 1
.2 0.8 0 26.4 70.5 2.3 0.8
2 2 47 72 2 1
.3 1.6 1.6 37.9 58.1 1.6 0.8
red to 1450 ppm F 50/121 (41.3%) p = 0.093; 6 months; 1.5% Arginine/
(58.1%) p = 0.038
he gingival margin (mm), lesion area (mm2) and number of
1450 MFP
N = 124
Significance of difference
1.36 (1.00) p = 0.12
0.58 (0.84) p = 0.56
3.06 (3.09) p = 0.022
3.46 (3.59) p = 0.80
Table 3 – Logistic regression analysis for lesion hardness at 6 months controlling for baseline mean plaque score, distance
of lesion from the gingival margin (mm), lesion area (mm2) and number of lesions.
B coefficient (SE) Sig. Exp (B) 95.0% C.I. for Exp(B)
Lower Upper
Plaque score 0.57 (0.17) 0.001 0.568 0.411 0.784
Distance from gingival margin 0.85 (0.25) 0.001 2.329 1.431 3.791
Baseline lesion area 0.07 (0.05) 0.14 0.934 0.852 1.023
Number of root caries lesions 0.05 (0.05) 0.27 0.949 0.865 1.041
Group 0.88 (0.30) 0.004 2.410 1.332 4.359
Table 4 – Baseline mean plaque score, distance of lesion from the gingival margin (mm), lesion area (mm2) and number of
lesions for lesions classified as hard or not hard at the 6-month examination (mean (SD)).
Not hard at 6-month examination
N = 90
Hard at 6-month examination
N = 163
Significance of difference
Lesion Plaque score 1.82 (0.87) 1.26 (1.02) p < 0.001
Distance from Gingival margin 0.28 (0.50) 0.70 (0.93) p < 0.001
Lesion area 4.69 (4.30) 2.99 (3.08) p = 0.001
Number of lesions 4.34 (4.35) 2.88 (2.68) p = 0.004
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lesions had become hard in the arginine-containing dentifrice
group compared to 40.3% in the positive control. During the
first 3 months of the study, one lesion was restored in the
arginine-containing dentifrice group and two lesions were
restored and one became soft in the positive control group.
The difference in the number of lesions becoming hard in the
arginine-containing dentifrice andpositive control groupswas
not statistically significant at the 3-month examination
(p = 0.09).
At the 6-month examination, 70.5% of lesions had become
hard in the arginine-containing dentifrice group compared to
58.1% in thepositive control group.During the6monthsof the
study, three lesions were restored and one was extracted in
the arginine-containing dentifrice group. In the positive
control group, two lesions were restored, one was extracted
and two became soft. The difference in the number of lesions
becoming hard in the arginine-containing dentifrice and
positive control groups was statistically significant
( p = 0.038).
The unadjusted odds ratio for lesions becoming in the
experimental group compared to the control was 1.73 (95% CI
1.03–2.91).A logistic regression analysiswas used to assess the
impact of the slight imbalance in baseline lesion character-
istics by comparing the odds ratio of lesions becoming hard
after controlling for baseline covariates (Table 3). The
significance of the difference between the two groups
increased from p = 0.038 to p = 0.004 using the logistic
regression analysis. The odds ratio for lesions becoming hard
between the two study groups increased to 2.41 (95% CI 1.33–
4.36) when the baseline covariates were included.4.3. Baseline characteristics and lesion hardness at 6
months
.
The baseline characteristics of subjects with lesions
becoming hard at 6 months were compared to those that
did not improve or became worse (Table 4). Lesions that
became hard had the following baseline characteristics onaverage: lesions had less plaque (p < 0.001), were further from
the gingival margin (p < 0.001), were smaller in area
(p < 0.001) and were present in subjects who had fewer root
caries lesions present (p = 0.004).5. Discussion
The highly successful introduction of fluoride has led to a
decrease in dental caries prevalence worldwide. Nonetheless,
there is abundant caries prevalence and severity data that
demonstrate that dental caries remains a global oral health
problem.1 Fluoridated dentifrice, in particular, has played a
significant role in controlling the caries process and prevent-
ing the formation of cavities by acting upon de-mineralized
tooth surfaces to re-mineralize and strengthen the enamel
and, thereby, to reverse and repair early caries lesions.
Fluoride also prevents de-mineralization because it reduces
the critical pH below which calcium and phosphate ions are
lost from the tooth surface.1 However, fluoride can not
completely prevent the caries process, because it does not
act upon dental plaque.
For this reason, a new dentifrice containing 1.5% arginine,
an insoluble calcium compound, and 1450 ppm fluoride, as
monofluorophosphate, has been developed. The combination
of arginine and an insoluble calcium compound complements
and enhances the effects of a fluoride dentifrice by addition-
ally targeting dental plaque to reduce its pathogenicity.1 The
arginine is metabolized to ammonia which helps to neutralize
plaque acids, to prevent shifts in biofilm flora to acid-
producing bacteria, such as S. mutans, and to maintain a
‘‘healthy’’ plaque after sugar challenge.21 Further, the insolu-
ble calcium compound acts a reservoir of free calcium ions to
enhance the re-mineralization process.20 This new dentifrice
containing 1.5% arginine, an insoluble calcium compound,
and 1450 ppm fluoride, as monofluorophosphate, has been
clinically proven to arrest and reverse early caries lesions
more effectively than control dentifrices containing fluoride
both in children with early coronal caries lesions and in older
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proven tomore effectively prevent the progression of caries to
cavitation than dentifrice with fluoride alone.24
Three coronal caries studies, using quantitative light-
induced fluorescence (QLF) to measure changes in early caries
lesions in children, have each shown that a new dentifrice
containing 1.5% arginine, and insoluble calcium compound
and 1450 ppm fluoride is significantly more effective in
arresting and reversing coronal caries lesions than a dentifrice
containing 1450 ppm fluoride alone.15,16,18 In one study, the
new dentifrice was compared to two control dentifrices: a
matched positive control containing 1450 ppm fluoride alone
and a matched fluoride-free negative control. After 6 months
product use, improvements from baseline in the representa-
tive parameterDQ (lesion volume)were 50.7, 32.3 and 11.4% for
the new arginine-containing dentifrice, the positive control
dentifrice, and the negative control dentifrice, respectively.
The differences between the negative control and the two
fluoride containing dentifrices (p < 0.001), as well as the
differences between the new dentifrice and the positive
control ( p = 0.003), were statistically significant.18 In a second
study, the new dentifrice was compared to two control
dentifrices; a positive control containing 1450 ppm fluoride
as sodium fluoride in a silica base and amatched fluoride-free
negative control. After 6 months product use, improvements
from baseline in the parameter DQ (lesion volume) were 50.6,
34.0 and 13.1% for the new arginine-containing dentifrice, the
positive control dentifrice and the negative control dentifrice,
respectively. Once again, the differences between the negative
control and the two fluoride containing dentifrices (p < 0.001),
as well as the differences between the new dentifrice and the
positive control (p = 0.008), were statistically significant.15 In a
third study, the new dentifrice was compared to a matched
positive control dentifrice containing 1450 ppmfluoride alone.
After 6 months product use, improvements from baseline in
the parameter DQ (lesion volume) were 44.6 and 28.9% for the
new arginine-containing dentifrice and the positive control
dentifrice, respectively. The difference between the new
dentifrice and the positive control was statistically significant
(p < 0.001).16
Two root caries studies in adults have each shown that the
new dentifrice containing 1.5% arginine and 1450 ppm
fluoride in a calcium base is significantly more effective in
arresting and reversing root caries lesions than a dentifrice
containing 1450 ppm fluoride alone. In one study, the new
dentifricewas compared to two control dentifrices: a positive
control containing 1450 ppmfluoride, as sodiumfluoride, in a
silica base, and a matched fluoride-free negative control.
After 6 months product use, clinical hardness measures
showed that only one lesion (0.7%) was worse in the new
dentifrice group compared to 9.0 and 18.2% in the positive and
negative control groups, respectively. In addition, 61.7, 56.0
and 27.0% lesions showed improvement for thenewarginine-
containing dentifrice, the positive control dentifrice and the
negative control dentifrice, respectively. The differences in
the distribution of lesion change scores between the negative
control and the two fluoride containing dentifrices
( p < 0.001), as well as the differences between the new
dentifrice and the positive control ( p = 0.006), were statisti-
cally significant.19The clinical study reported in this paper is the second of the
root caries studies and compared the new dentifrice to a
matchedpositive control containing 1450 ppm.After 6months
product use, 70.5% of root caries lesions improved for subjects
using the new dentifrice compared to 58.1% for subjects in the
positive control group. The difference in the number of root
caries lesions being hardened in the new dentifrice and
positive control groups was statistically significant (p < 0.05).
Thus, this study confirmed the hypothesis that the new
dentifrice was more effective in hardening root caries lesions
in adults than a marketed positive control dentifrice contain-
ing 1450 ppm fluoride alone. The results support the findings
of the other four clinical studies.15–19
Together, these five studies show that a new dentifrice
containing 1.5% arginine, an insoluble calcium compound,
and 1450 ppm fluoride, as monofluorophosphate, is clinically
proven to arrest and reverse early caries lesions more
effectively in both children and adults than control dentifrices
containing fluoride alone.
Finally, a 2-year conventional caries clinical study has
proven that two dentifrices containing 1.5% arginine and
1450 ppm fluoride in a calcium base, one with di-calcium
phosphate and the other with calcium carbonate, are
significantly more effective in preventing the formation of
cavitated caries lesions than a dentifrice containing 1450 ppm
fluoride alone. Three trained and calibrated dentists examined
the children at baseline and after one and two years using the
National Institute of Dental Research Diagnostic Procedures
and Criteria. The number of decayed, missing, and filled teeth
(DMFT) and surfaces (DMFS) for the three study groups were
very similar at baseline, with no statistically significant
differences among groups. After one year, there were no
statistically significant differences in caries increments
among the three groups. After two years, the two groups
using the dentifrices containing 1.5% arginine, an insoluble
calcium compound and 1450 ppm F had statistically signifi-
cantly (p < 0.02) lower DMFT increments (21.0% and 17.7%
reductions, respectively) and DMFS increments (16.5% and
16.5%) compared to the control dentifrice. The differences
between the two groups using the new dentifrices were not
statistically significant. The results of this pivotal clinical
study support the conclusion that dentifrices containing 1.5%
arginine, an insoluble calcium compound, and 1450 ppm
fluoride provide superior protection against caries lesion
cavitation to dentifrices containing 1450 ppm fluoride alone.246. Conclusion
This studydemonstrates thatuseofanewdentifrice containing
1.5% arginine, an insoluble calcium compound, and 1450 ppm
fluoride, as monofluorophosphate, statistically significantly
enhances the re-mineralization of root caries lesions as
compared to use of a dentifrice containing fluoride alone.Conflict of interest
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